Conway Bio completed A+ round of financing of over 100 million yuan
Kangwei Bio is a research and development manufacturer of new anti-tumor drugs, focusing on health science project research, development, medical research, drug research and development, etc., and is committed to providing cancer treatment drugs for patients. Recently, Kangwei Bio completed the A+ round of financing of over 100 million yuan, which was exclusively invested by […]
Conway Bio completed A+ round of financing of over 100 million yuan Read More »